HomeNRIX • NASDAQ
add
Nurix Therapeutics Inc
Previous close
$15.45
Day range
$13.86 - $15.51
Year range
$11.90 - $29.56
Market cap
1.08B USD
Avg Volume
685.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Nov 2024info | Y/Y change |
---|---|---|
Revenue | 13.28M | -12.37% |
Operating expense | 10.72M | -0.58% |
Net income | -58.55M | -39.55% |
Net profit margin | -440.75 | -59.25% |
Earnings per share | -0.75 | 2.60% |
EBITDA | -63.41M | -41.54% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Nov 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 609.58M | 111.73% |
Total assets | 669.34M | 88.23% |
Total liabilities | 142.35M | -8.22% |
Total equity | 526.99M | — |
Shares outstanding | 75.89M | — |
Price to book | 2.22 | — |
Return on assets | -27.33% | — |
Return on capital | -33.70% | — |
Cash Flow
Net change in cash
(USD) | Nov 2024info | Y/Y change |
---|---|---|
Net income | -58.55M | -39.55% |
Cash from operations | -48.75M | -282.66% |
Cash from investing | -140.82M | -879.73% |
Cash from financing | 200.52M | 2,864,485.71% |
Net change in cash | 10.95M | -11.12% |
Free cash flow | -23.42M | -510.58% |
About
Founded
2009
Headquarters
Website
Employees
286